Skip to content

Randomized controlled trial of mindfulness-based stress reduction for prehypertension.

Joel W Hughes, David M. Fresco, Rodney Myerscough, Manfred H M Van Dulmen, Linda E. Carlson, Richard Josephson

Psychosomatic Medicine October 1, 2013 DOI: 10.1097/psy.0b013e3182a3e4e5 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 56
Population Men (43%) and women (57%) averaging 50.3 years of age (SD 6.5), 91% white, with unmedicated blood pressure in the prehypertensive range (SBP 120-139 mm Hg or DBP 80-89 mm Hg)
Interventions Mindfulness-based stress reduction (MBSR) Progressive muscle relaxation (PMR)
Duration 8 weeks of treatment; weekly sessions lasting approximately 2.5 hours
Topics Meditation
Keywords Humans Analysis of variance Linear models Stress, psychological Blood pressure Adult Middle aged Patient dropouts Female Relaxation therapy Prehypertension Clinical trial
Registration NCT00440596
Key findings MBSR produced a 4.8 mm Hg reduction in clinic systolic blood pressure versus 0.7 mm Hg for progressive muscle relaxation, and a 1.9 mm Hg reduction in diastolic pressure versus a 1.2 mm Hg increase for PMR. MBSR did not yield larger reductions in ambulatory blood pressure than PMR.

Abstract

Objective: Mindfulness-based stress reduction (MBSR) is an increasingly popular practice demonstrated to alleviate stress and treat certain health conditions. MBSR may reduce elevated blood pressure (BP). Treatment guidelines recommend life-style modifications for BP in the prehypertensive range (systolic BP [SBP] 120-139 mm Hg or diastolic BP [DBP] 80-89 mm Hg), followed by antihypertensives if BP reaches hypertensive levels. MBSR has not been thoroughly evaluated as a treatment of prehypertension. A randomized clinical trial of MBSR for high BP was conducted to determine whether BP reductions associated with MBSR exceed those observed for an active control condition consisting of progressive muscle relaxation (PMR) training.

Methods: Fifty-six men (43%) and women (57%) averaging (standard deviation) 50.3 (6.5) years of age (91% white) with unmedicated BP in the prehypertensive range were randomized to 8 weeks of MBSR or PMR delivered in a group format. Treatment sessions were administered by one treatment provider and lasted approximately 2.5 hours each week. Clinic BP was the primary outcome measure. Ambulatory BP was a secondary outcome measure.

Results: Analyses were based on intent to treat. Patients randomized to MBSR exhibited a 4.8-mm Hg reduction in clinic SBP, which was larger than the 0.7-mm Hg reduction observed for PMR (p = .016). Those randomized to MBSR exhibited a 1.9-mm Hg reduction in DBP compared with a 1.2-mm Hg increase for PMR (p = .008). MBSR did not result in larger decreases in ambulatory BP than in PMR.

Conclusions: MBSR resulted in a reduction in clinic SBP and DBP compared with PMR.

Trial Registration: ClinicalTrials.gov identifier: NCT00440596.

Comparable studies

Other randomized controlled trials on meditation, most cited first.

Study Year Design Participants
Alterations in Brain and Immune Function Produced by Mindfulness Meditation Healthy employees in a work environment 2003 Randomized controlled trial n = 41
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Open hearts build lives: Positive emotions, induced through loving-kindness meditation, build consequential personal resources. Working adults 2008 Randomized controlled trial n = 139
Short-term meditation training improves attention and self-regulation Undergraduate Chinese students 2007 Randomized controlled trial n = 40
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Explore topics